BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aref S, Mabed M, Selim T, Goda T, Khafagy N. Thrombopoietin (TPO) levels in hepatic patients with thrombocytopenia. Hematology. 2004;9:351-356. [PMID: 15763973 DOI: 10.1080/10245330400010620] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Reusswig F, Fazel Modares N, Brechtenkamp M, Wienands L, Krüger I, Behnke K, Lee-Sundlov MM, Herebian D, Scheller J, Hoffmeister KM, Häussinger D, Elvers M. Efficiently Restored Thrombopoietin Production by Ashwell-Morell Receptor and IL-6R Induced Janus Kinase 2/Signal Transducer and Activator of Transcription Signaling Early After Partial Hepatectomy. Hepatology 2021;74:411-27. [PMID: 33369745 DOI: 10.1002/hep.31698] [Reference Citation Analysis]
2 Osada M, Kaneko M, Sakamoto M, Endoh M, Takigawa K, Suzuki-Inoue K, Inoue O, Satoh K, Enomoto N, Yatomi Y, Ozaki Y. Causes of thrombocytopenia in chronic hepatitis C viral infection. Clin Appl Thromb Hemost 2012;18:272-80. [PMID: 22327815 DOI: 10.1177/1076029611429124] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
3 Sekiguchi T, Nagamine T, Takagi H, Mori M. Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C. World J Gastroenterol 2006;12:1205-10. [PMID: 16534872 DOI: 10.3748/wjg.v12.i8.1205] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
4 Dou J, Lou Y, Wu J, Lu Y, Jin Y. Thrombocytopenia in patients with hepatitis B virus-related chronic hepatitis: evaluation of the immature platelet fraction. Platelets. 2014;25:399-404. [PMID: 24047408 DOI: 10.3109/09537104.2013.832742] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
5 Speth C, Löffler J, Krappmann S, Lass-flörl C, Rambach G. Platelets as immune cells in infectious diseases. Future Microbiology 2013;8:1431-51. [DOI: 10.2217/fmb.13.104] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 6.5] [Reference Citation Analysis]
6 Chen YC, Ko PH, Lee CC, Tseng CW, Tseng KC. Baseline thrombopoietin level is associated with platelet count improvement in thrombocytopenic chronic hepatitis C patients after successful direct-acting antiviral agent therapy. BMC Gastroenterol 2021;21:30. [PMID: 33478399 DOI: 10.1186/s12876-021-01606-x] [Reference Citation Analysis]
7 Temel T, Cansu DU, Temel HE, Ozakyol AH. Serum thrombopoietin levels and its relationship with thrombocytopenia in patients with cirrhosis. Hepat Mon 2014;14:e18556. [PMID: 24976834 DOI: 10.5812/hepatmon.18556] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
8 Zermatten MG, Fraga M, Moradpour D, Bertaggia Calderara D, Aliotta A, Stirnimann G, De Gottardi A, Alberio L. Hemostatic Alterations in Patients With Cirrhosis: From Primary Hemostasis to Fibrinolysis. Hepatology 2020;71:2135-48. [PMID: 32090357 DOI: 10.1002/hep.31201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
9 Wang Y, Wang L, Gao W, Chen X, Su Y. Detection of Treg/Th17 cells and related cytokines in peripheral blood of chronic hepatitis B patients combined with thrombocytopenia and the clinical significance. Exp Ther Med 2018;16:1328-32. [PMID: 30112063 DOI: 10.3892/etm.2018.6311] [Reference Citation Analysis]
10 Blonski W, Siropaides T, Reddy KR. Coagulopathy in liver disease. Curr Treat Options Gastroenterol 2007;10:464-73. [PMID: 18221607 DOI: 10.1007/s11938-007-0046-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
11 Tejima K, Masuzaki R, Ikeda H, Yoshida H, Tateishi R, Sugioka Y, Kume Y, Okano T, Iwai T, Gotoh H. Thrombocytopenia is more severe in patients with advanced chronic hepatitis C than B with the same grade of liver stiffness and splenomegaly. J Gastroenterol. 2010;45:876-884. [PMID: 20339877 DOI: 10.1007/s00535-010-0233-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
12 Aref S, Ibrahem L, El Menshawy N, Bassam A. Effect of splenectomy on platelets associated antibodies in hepatitis C patients with thrombocytopenia. Hematology 2012;17:118-21. [PMID: 22664051 DOI: 10.1179/102453312X13221316477705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Eissa LA, Gad LS, Rabie AM, El-gayar AM. Thrombopoietin level in patients with chronic liver diseases. Annals of Hepatology 2008;7:235-44. [DOI: 10.1016/s1665-2681(19)31854-x] [Cited by in Crossref: 15] [Article Influence: 1.2] [Reference Citation Analysis]
14 Witters P, Freson K, Verslype C, Peerlinck K, Hoylaerts M, Nevens F, Van Geet C, Cassiman D. Review article: Blood platelet number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther. 2008;27:1017-1029. [PMID: 18331464 DOI: 10.1111/j.1365-2036.2008.03674.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 77] [Article Influence: 7.8] [Reference Citation Analysis]
15 Giannini EG. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options. Aliment Pharmacol Ther. 2006;23:1055-1065. [PMID: 16611265 DOI: 10.1111/j.1365-2036.2006.02889.x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 101] [Article Influence: 8.3] [Reference Citation Analysis]
16 Huang CE, Chen YY, Chang JJ, Kuan FC, Lee KD, Lu CH, Lung J, Shen CH, Chen CC. Thrombopoietic cytokines in patients with hepatitis C virus-associated immune thrombocytopenia. Hematology 2017;22:54-60. [PMID: 27396368 DOI: 10.1080/10245332.2016.1204493] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
17 Aref S, Sleem T, El Menshawy N, Ebrahiem L, Abdella D, Fouda M, Samara NA, Menessy A, Abdel-Ghaffar H, Bassam A. Antiplatelet antibodies contribute to thrombocytopenia associated with chronic hepatitis C virus infection. Hematology. 2009;14:277-281. [PMID: 19843383 DOI: 10.1179/102453309x439818] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
18 Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol 2011;55:1415-27. [PMID: 21718668 DOI: 10.1016/j.jhep.2011.06.008] [Cited by in Crossref: 107] [Cited by in F6Publishing: 80] [Article Influence: 10.7] [Reference Citation Analysis]
19 Kalambokis GN, Mouzaki A, Rodi M, Tsianos EV. Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia. Liver Int. 2012;32:467-475. [PMID: 22098272 DOI: 10.1111/j.1478-3231.2011.02650.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]